SCI Pharmtech, Inc. (4119.TW)
TWD 89.9
(-0.66%)
TWD 89.9
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 215.76 Million | 296.56 Million | 280.27 Million | 971.52 Million | 791.59 Million | 480.18 Million |
| Net Income | 364.19 Million | 387.82 Million | 65.5 Million | 455.21 Million | 711.16 Million | 544.78 Million |
| Depreciation & Amortization | 145.29 Million | 90.61 Million | 63.7 Million | 133.3 Million | 136.73 Million | 132.4 Million |
| Deferred income taxes | 8.52 Million | - | - | - | - | -55.93 Million |
| Stock-based compensation | 18.72 Million | - | - | - | - | 160 Thousand |
| Change in working capital | -323.43 Million | -108.52 Million | 260.99 Million | -31.42 Million | 72.2 Million | -141.2 Million |
| Other non-cash items | 2.47 Million | -73.34 Million | -109.92 Million | 414.43 Million | -128.49 Million | -23 Thousand |
| Investing Cash Flow | -866.2 Million | -1 Billion | -539.56 Million | -428.99 Million | -263.47 Million | -203.97 Million |
| Investments in PPE | -1.02 Billion | -1.16 Billion | -774.98 Million | -217.7 Million | -204.48 Million | -162.44 Million |
| Acquisitions | -18 Million | -92.75 Million | -66 Million | 74 Thousand | -4.97 Million | 81 Thousand |
| Investment purchases | -3.98 Million | -2.12 Million | -8.53 Million | -217.63 Million | -113.92 Million | -43.76 Million |
| Sales/Maturities of investments | 185.24 Million | 250.9 Million | 311.95 Million | -74 Thousand | 50.64 Million | - |
| Other Investing Activities | -110 Thousand | 2.46 Million | -2 Million | 6.34 Million | 9.26 Million | 2.22 Million |
| Financing Cash Flow | 1.42 Billion | 547.11 Million | -41.51 Million | -463.06 Million | -335.74 Million | -170.89 Million |
| Debt repayment | -493.8 Million | -678 Million | -1.77 Million | -2.04 Million | -1.91 Million | - |
| Dividends payments | -23.84 Million | - | -39.74 Million | -461.01 Million | -333.83 Million | -170.89 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 957.6 Million | - | - | - | - | - |
| Other Financing Activities | 491.91 Million | 1.22 Billion | -1.77 Million | -2.04 Million | -1.91 Million | - |
| Accounts receivables | -128.09 Million | 175.9 Million | 494.44 Million | 15.83 Million | 38.51 Million | -218.46 Million |
| Accounts payables | -4.38 Million | 14.85 Million | -47.09 Million | -13.42 Million | 5.14 Million | 53.97 Million |
| Inventory | -16.1 Million | -219.24 Million | 86.69 Million | -29.36 Million | -24 Million | -22.21 Million |
| Other working capital | -174.84 Million | -80.03 Million | -273.05 Million | -4.47 Million | 52.55 Million | -118.99 Million |
| Cash at beginning of period | 166.82 Million | 332.23 Million | 633.02 Million | 553.55 Million | 361.18 Million | 255.86 Million |
| Cash at end of period | 942.05 Million | 166.82 Million | 332.23 Million | 633.02 Million | 553.55 Million | 361.18 Million |
| Capital Expenditure | -1.02 Billion | -1.16 Billion | -774.98 Million | -217.7 Million | -204.48 Million | -162.44 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 775.22 Million | -165.4 Million | -300.79 Million | 79.47 Million | 192.37 Million | 105.31 Million |
| Free Cash Flow | -813.59 Million | -871.01 Million | -494.7 Million | 753.82 Million | 587.1 Million | 317.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 62.19 Million | 55.84 Million | 364.19 Million | -10.29 Million | 44.42 Million | 251.33 Million |
| Depreciation & Amortization | 59.88 Million | 51.13 Million | 145.29 Million | 44.88 Million | 35.99 Million | 32.57 Million |
| Deferred income taxes | - | - | 8.52 Million | -18.72 Million | - | - |
| Stock-based compensation | - | - | 18.72 Million | 18.72 Million | - | - |
| Change in working capital | -185.25 Million | 2.01 Million | -323.43 Million | -32.26 Million | -19.82 Million | -12.32 Million |
| Other non-cash items | 284.03 Million | 2.48 Million | 2.47 Million | 25.64 Million | 4.54 Million | -135 Thousand |
| Investing Cash Flow | -63.97 Million | -128.46 Million | -866.2 Million | -345.41 Million | -225.8 Million | 5.96 Million |
| Investments in PPE | -79.79 Million | -138.23 Million | -1.02 Billion | -361.74 Million | -317.16 Million | -47.06 Million |
| Acquisitions | - | - | -18 Million | - | 3.98 Million | 18 Million |
| Investment purchases | - | - | -3.98 Million | - | -3.98 Million | -18 Million |
| Sales/Maturities of investments | 16.61 Million | 9.77 Million | 185.24 Million | 16.32 Million | 95.33 Million | 71.14 Million |
| Other Investing Activities | -800 Thousand | 9.77 Million | -110 Thousand | 16.32 Million | -3.98 Million | -18.11 Million |
| Financing Cash Flow | 97.82 Million | -13.03 Million | 1.42 Billion | 1.11 Billion | 157.48 Million | -233.32 Million |
| Debt repayment | -98.32 Million | -12.53 Million | -493.8 Million | -161.88 Million | -181.83 Million | -232.83 Million |
| Dividends payments | - | - | -23.84 Million | - | -23.84 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 957.6 Million | 957.6 Million | - | - |
| Other Financing Activities | -502 Thousand | -109 Million | 491.91 Million | 992.6 Million | 363.17 Million | -487 Thousand |
| Accounts receivables | -144.51 Million | 64.33 Million | -128.09 Million | -31.57 Million | 9.2 Million | -54.66 Million |
| Accounts payables | -25.48 Million | 33.13 Million | -4.38 Million | 12.58 Million | -5.02 Million | -10.12 Million |
| Inventory | -34.09 Million | -71.64 Million | -16.1 Million | -10.45 Million | -31.63 Million | 33.61 Million |
| Other working capital | 18.82 Million | -23.8 Million | -174.84 Million | -2.81 Million | 7.63 Million | 18.84 Million |
| Cash at beginning of period | 915.96 Million | 942.05 Million | 166.82 Million | 140.51 Million | 143.7 Million | 99.6 Million |
| Cash at end of period | 846.82 Million | 915.96 Million | 942.05 Million | 942.05 Million | 140.51 Million | 143.7 Million |
| Capital Expenditure | -79.79 Million | -138.23 Million | -1.02 Billion | -361.74 Million | -317.16 Million | -47.06 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -69.14 Million | -26.09 Million | 775.22 Million | 801.54 Million | -3.18 Million | 44.09 Million |
| Free Cash Flow | -182.78 Million | -22.82 Million | -813.59 Million | -333.77 Million | -252.02 Million | 224.38 Million |
095720
AOF
NYMT
SFPI
DIGAF
SANION